Camurus AB   Report issue

For profit Phase 2 Phase 3 Phase 4
Founded: Lund Sweden (1991)

Organization Overview

First Clinical Trial
2011
NCT01316393
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2021

Timeline

NOW
  • Now

Alternative names

Camurus AB